MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • 2016 International Congress

    Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV

    N. Prinz, L. Wang, J. Stingl, M.D. Denkinger, P. Fasching, P.M. Jehle, S. Merger, S. Mühldorfer, A. Schuler, A. Zeyfang, M. Sharma, R.W. Holl (Ulm, Germany)

    Objective: To study the presence of dementia in older people with Type 2 diabetes mellitus (T2DM) and to compare demographics with non-demented T2DM patients. Background:…
  • 2016 International Congress

    Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

    A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)

    Objective: To report the statistical analyses exploring the association between BMI and change in Unified Parkinson's disease Rating Scale (UPDRS) scores and survival in the…
  • 2016 International Congress

    Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

    F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)

    Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…
  • 2016 International Congress

    Prevalence of Parkinson’s disease in Ukraine

    Y.O. Trufanov, N.K. Svyrydova, A.I. Galusha, G.M. Chupryna, O.V. Popov, M.V. Nechkalyuk (Kyiv, Ukraine)

    Objective: To compare the prevalence of Parkinson's disease (PD) in Ukraine in 2010 and 2014; to compare the prevalence of PD in Ukraine with other…
  • 2016 International Congress

    Underutilization of physiotherapy for Parkinson’s disease in the United States

    M.E. Fullard, D.P. Thibault, A. Hill, J. Fox, A.W. Willis (Philadelphia, PA, USA)

    Objective: To examine allied health care (AHC) utilization in older adults with Parkinson's disease in the United States. Background: Multiple studies have demonstrated the efficacy…
  • 2016 International Congress

    Burden of movement disorders in Cameroon: In/out patient population study

    J.N. Doumbe, Y. Mapoure, E. Cubo, T. Nyinyikua, K. Kompoliti (Douala, Cameroon)

    Objective: To create a registry and surveillance of neurological disease from health care districts in Cameroon from 2012 to 2014. Background: Due to rapid demographic…
  • 2016 International Congress

    Phenotypic differences between African American and Caucasian Parkinson’s disease patients

    M.O. Bailey, B. Ouyang, G.T. Stebbins, L.M. Shulman, L.L. Barnes, D.A. Hall (Chicago, IL, USA)

    Objective: To determine phenotypic differences between African American (AA) and Caucasian patients with Parkinson's disease (PD) at Rush University Medical Center (RUMC) Movement Disorders Clinic.…
  • 2016 International Congress

    Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

    M. Salari (Isfahan, Islamic Republic of Iran)

    Objective: To evaluated demographic and clinical characteristic feature of patients with Parkinson's disease in Isfahan city in Iran. Background: Parkinson's disease (PD) is one of…
  • 2016 International Congress

    Predictors of transfer to community hospital or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

    K. Ikeda, K. Takahashi, T. Furuya, A. Miyake, T. Mitsufuji, A. Tanaka, Y. Ito, T. Sasaki, Y. Nakazato, N. Araki, T. Yamamoto (Saitama-ken, Japan)

    Objective: To investigate the reasons for hospital admissions for patients with Parkinson's disease (PD) and to determine the predictors of transfer to community hospital or…
  • « Previous Page
  • 1
  • …
  • 1388
  • 1389
  • 1390
  • 1391
  • 1392
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley